Data as of Jul 24
| +0.04 / +1.32%|
The 1 analysts offering 12-month price forecasts for Biota Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +62.34% increase from the last price of 3.08.
The current consensus among 1 polled investment analysts is to Buy stock in Biota Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.